Erem, C. Et Al. 2009. Blood coagulation and fibrinolysis in patients with Cushing's syndrome: Increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION , vol.32, no.2 , 169-174.

Erem, C., Nuhoglu, İ., YILMAZ, M., KOÇAK, M., DEMİREL, A., ÜÇÜNCÜ, O., ... Ersoz, H. O.(2009). Blood coagulation and fibrinolysis in patients with Cushing's syndrome: Increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION , vol.32, no.2, 169-174.

Erem, CİHANGİR Et Al. "Blood coagulation and fibrinolysis in patients with Cushing's syndrome: Increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels," JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION , vol.32, no.2, 169-174, 2009

Erem, CİHANGİR Et Al. "Blood coagulation and fibrinolysis in patients with Cushing's syndrome: Increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels." JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION , vol.32, no.2, pp.169-174, 2009

Erem, C. Et Al. (2009) . "Blood coagulation and fibrinolysis in patients with Cushing's syndrome: Increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels." JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION , vol.32, no.2, pp.169-174.

@article{article, author={CİHANGİR EREM Et Al. }, title={Blood coagulation and fibrinolysis in patients with Cushing's syndrome: Increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels}, journal={JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION}, year=2009, pages={169-174} }